卡利拉嗪是一種非典型抗精神病藥物，用于治療精神分裂癥和躁郁癥。它主要作用于D3受體和D2受體部分激動劑，對D3受體具有高選擇性。在2012年早期，針對精神分裂癥和躁狂癥，以及2015年II期試驗中針對雙相情感障礙I型抑郁癥，發(fā)表了積極的III期研究結(jié)果。它也可能是有用的附加治療抑郁癥。
tert-Butyl piperazine-1-carboxylate
3-(trans-4-(2-(4-(2,3-Dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)-1,1-dimethylurea hydrochloride
1-Bromo-2,3-dichlorobenzene
tert-Butyl (trans-4-(2-hydroxyethyl)cyclohexyl)carbamate
Ethyl 2-(trans-4-((tert-butoxycarbonyl)amino)cyclohexyl)acetate
Ethyl 2-(diethoxyphosphoryl)acetate
4-Nitrophenylacetic acid
tert-Butyl (trans-4-(2-oxoethyl)cyclohexyl)carbamate
trans-4-(2-(4-(2,3-Dichlorophenyl)piperazin-1-yl)ethyl)cyclohexan-1-amine
4-Aminocyclohexanone
ethyl 2-[(1r,4r)-4-[(dimethylcarbamoyl)amino]cyclohexyl]acetate
3,3-dimethyl-1-[(1r,4r)-4-(2-oxoethyl)cyclohexyl]urea
3-(trans-4-(2-Hydroxyethyl)cyclohexyl)-1,1-dimethylurea
tert-Butyl ((1R,4R)-4-(2-(4-(2,3-dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)carbamate
